NASDAQ:LFST LifeStance Health Group (LFST) Stock Price, News & Analysis → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free LFST Stock Alerts $5.28 -0.07 (-1.31%) (As of 06/11/2024 ET) Add Compare Share Share Today's Range$5.10▼$5.3950-Day Range$5.28▼$7.5152-Week Range$4.74▼$9.59Volume1.40 million shsAverage Volume1.47 million shsMarket Capitalization$2.02 billionP/E RatioN/ADividend YieldN/APrice Target$8.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get LifeStance Health Group alerts: Email Address LifeStance Health Group MarketRank™ Stock AnalysisAnalyst RatingHold2.20 Rating ScoreUpside/Downside66.7% Upside$8.80 Price TargetShort InterestBearish17.30% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingSelling Shares$23.12 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.27) to ($0.23) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.85 out of 5 starsMedical Sector786th out of 905 stocksHealth Services Industry7th out of 10 stocks 3.1 Analyst's Opinion Consensus RatingLifeStance Health Group has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 2 buy ratings, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageLifeStance Health Group has only been the subject of 1 research reports in the past 90 days.Read more about LifeStance Health Group's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted17.30% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 12.2, which indicates bearish sentiment.Change versus previous monthShort interest in LifeStance Health Group has recently decreased by 0.77%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LFST. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for LifeStance Health Group this week, compared to 2 articles on an average week.Search Interest2 people have searched for LFST on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $23,117,200.00 in company stock.Percentage Held by InsidersOnly 6.60% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LifeStance Health Group's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for LifeStance Health Group are expected to grow in the coming year, from ($0.27) to ($0.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is -11.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is -11.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 1.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about LifeStance Health Group's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $0.35, AMZN under $2.50, and NVDA before it soared 1,200%. Recently, he sat down for an exclusive interview, revealing EXACTLY where to put your money this year. An investment vehicle he's so confident in, he says he'd put 50% of his kids' inheritance into this stock.You can get the name and ticker symbol, absolutely free, right here. About LifeStance Health Group Stock (NASDAQ:LFST)LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Read More LFST Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LFST Stock News HeadlinesMay 30, 2024 | insidertrades.comSummit Partners Growth Equity Sells 3,802,345 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) StockMay 15, 2024 | insidertrades.comInsider Selling: LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Sells 2,000 Shares of StockMay 15, 2024 | insidertrades.comLifeStance Health Group, Inc. (NASDAQ:LFST) Insider Paula Cipollone Sells 48,278 SharesMay 25, 2024 | morningstar.comLifeStance Health Group Inc Ordinary Shares LFSTMay 23, 2024 | globenewswire.comLifeStance to Participate in Upcoming Investor ConferencesMay 23, 2024 | seekingalpha.comLifeStance: Selloff Opens Buying Opportunity Thanks To Price/Value DislocationMay 22, 2024 | msn.comWhy Lifestance Health Group (LSFT) Stock Is FallingMay 22, 2024 | investorplace.comWhy Is LifeStance Health (LFST) Stock Down 20% Today?May 22, 2024 | msn.comLifeStance Health stock dips 11%, prices secondary offering at 6.25May 21, 2024 | globenewswire.comLifeStance Health Group Announces Pricing of Secondary Public OfferingMay 21, 2024 | marketwatch.comLifeStance Health Group Shares Fall After Public Offering NewsMay 21, 2024 | globenewswire.comLifeStance Health Group Announces Launch of Secondary Public OfferingMay 13, 2024 | finance.yahoo.comLifeStance Health Group, Inc. (NASDAQ:LFST) Q1 2024 Earnings Call TranscriptMay 12, 2024 | finance.yahoo.comEarnings Update: Here's Why Analysts Just Lifted Their LifeStance Health Group, Inc. (NASDAQ:LFST) Price Target To US$8.79May 10, 2024 | markets.businessinsider.comBarclays Reaffirms Their Sell Rating on Lifestance Health Group (LFST)May 10, 2024 | finance.yahoo.comLifeStance Health Group Inc (LFST) Q1 2024 Earnings: Misses on Revenue, Narrows Net LossMay 9, 2024 | finanznachrichten.deLifeStance Health Group, Inc.: LifeStance Reports First Quarter 2024 ResultsMay 9, 2024 | msn.comLifeStance Health Group GAAP EPS of -$0.06, revenue of $300.4MMay 9, 2024 | globenewswire.comLifeStance Reports First Quarter 2024 ResultsMay 1, 2024 | prnewswire.comLifeStance Destigmatizes Mental Health in Newest "Not One Face" Campaign Featuring Photography from Leica AmbassadorsApril 30, 2024 | markets.businessinsider.comLifeist Announces Common Share ConsolidationApril 28, 2024 | nasdaq.comCommit To Purchase LifeStance Health Group At $4, Earn 13.7% Annualized Using OptionsApril 27, 2024 | nasdaq.comLifeStance Health Group, Inc. Common Stock (LFST)April 20, 2024 | finance.yahoo.comLifeStance Health Group, Inc. (LFST)April 18, 2024 | globenewswire.comLifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024See More Headlines Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today6/11/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:LFST CUSIPN/A CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees9,325Year FoundedN/APrice Target and Rating Average Stock Price Target$8.80 High Stock Price Target$10.00 Low Stock Price Target$8.00 Potential Upside/Downside+66.7%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-186,260,000.00 Net Margins-15.69% Pretax Margin-17.13% Return on Equity-11.92% Return on Assets-8.09% Debt Debt-to-Equity Ratio0.20 Current Ratio1.18 Quick Ratio1.18 Sales & Book Value Annual Sales$1.06 billion Price / Sales1.91 Cash FlowN/A Price / Cash FlowN/A Book Value$3.77 per share Price / Book1.40Miscellaneous Outstanding Shares382,290,000Free Float357,057,000Market Cap$2.02 billion OptionableOptionable Beta1.24 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Kenneth Alan Burdick (Age 65)CEO & Chairman Comp: $1.41MMr. Danish J. Qureshi (Age 39)President & COO Comp: $634.21kMr. David Patrick Bourdon (Age 54)Chief Financial Officer & Treasurer Comp: $906.95kMr. Ryan Pardo (Age 47)Chief Legal Officer & Secretary Comp: $508.95kMr. Pablo Pantaleoni (Age 35)Chief Digital Officer Comp: $652.09kMs. Monica ProkockiVice President of Investor RelationsBrooke MatthewsDirector of Public RelationsMs. Ann Varanakis (Age 46)Chief People Officer Mr. Kevin Michael Mullins (Age 38)Chief Development Officer Ms. Paula Wood (Age 47)Chief Business Transformation Officer More ExecutivesKey CompetitorsPrivia Health GroupNASDAQ:PRVAPremierNASDAQ:PINCApollo MedicalNASDAQ:AMEHAlignment HealthcareNASDAQ:ALHCMagellan HealthNASDAQ:MGLNView All CompetitorsInsiders & InstitutionsSummit Partners Growth EquitySold 3,802,345 sharesTotal: $22.40 M ($5.89/share)Virtu Financial LLCBought 17,108 shares on 5/20/2024Ownership: 0.004%California State Teachers Retirement SystemBought 11,022 shares on 5/16/2024Ownership: 0.025%Bayesian Capital Management LPBought 38,600 shares on 5/16/2024Ownership: 0.010%Price T Rowe Associates Inc. MDBought 4,681 shares on 5/15/2024Ownership: 0.011%View All Insider TransactionsView All Institutional Transactions LFST Stock Analysis - Frequently Asked Questions Should I buy or sell LifeStance Health Group stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for LifeStance Health Group in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" LFST shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LFST, but not buy additional shares or sell existing shares. View LFST analyst ratings or view top-rated stocks. What is LifeStance Health Group's stock price target for 2024? 5 Wall Street research analysts have issued twelve-month price targets for LifeStance Health Group's shares. Their LFST share price targets range from $8.00 to $10.00. On average, they anticipate the company's stock price to reach $8.80 in the next year. This suggests a possible upside of 66.7% from the stock's current price. View analysts price targets for LFST or view top-rated stocks among Wall Street analysts. How have LFST shares performed in 2024? LifeStance Health Group's stock was trading at $7.83 on January 1st, 2024. Since then, LFST stock has decreased by 32.6% and is now trading at $5.28. View the best growth stocks for 2024 here. When is LifeStance Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our LFST earnings forecast. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) released its earnings results on Thursday, May, 9th. The company reported ($0.06) earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $0.03. The firm had revenue of $300.44 million for the quarter, compared to analyst estimates of $299.02 million. LifeStance Health Group had a negative trailing twelve-month return on equity of 11.92% and a negative net margin of 15.69%. The business's revenue for the quarter was up 18.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.09) earnings per share. What ETFs hold LifeStance Health Group's stock? ETFs with the largest weight of LifeStance Health Group (NASDAQ:LFST) stock in their portfolio include Fidelity Disruptive Medicine ETF (FMED) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). What guidance has LifeStance Health Group issued on next quarter's earnings? LifeStance Health Group issued an update on its second quarter 2024 earnings guidance on Thursday, May, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $297.0 million-$315.0 million, compared to the consensus revenue estimate of $305.0 million. When did LifeStance Health Group IPO? LifeStance Health Group (LFST) raised $640 million in an IPO on Thursday, June 10th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair acted as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are LifeStance Health Group's major shareholders? LifeStance Health Group's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.01%), Principal Financial Group Inc. (1.04%), Jennison Associates LLC (0.51%), O Brien Wealth Partners LLC (0.14%), Hemington Wealth Management (0.10%) and Swiss National Bank (0.05%). Insiders that own company stock include Anisha Patel-Dunn, Ann Varanakis, Danish J Qureshi, David Bourdon, Gwen H Booth, Jeffrey Crisan, Jesse Michael Bruff, Kenneth T Mills, Kevin Michael Mullins, Michael K Lester, Paula Cipollone, Ryan Pardo, Silversmith Partners I Gp, Llc, Summit Partners Growth Equity and Warren Gouk. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:LFST) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeStance Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.